openPR Logo
Press release

Injectable Drug Delivery Market Set to Grow at 11.5% CAGR and Projected to Reach US$ 624.50 Billion to 2023 - Dominated by Becton, Dickinson and Company (U.S.), Baxter International (U.S.), Pfizer (U.S.), Gerresheimer AG (Germany) an Schott AG (Germany)

02-27-2019 02:48 PM CET | Health & Medicine

Press release from: ReportsnReports

Injectable Drug Delivery Market 2021

Injectable Drug Delivery Market 2021

Injectable Drug Delivery Market Study Report is Ready with PDF Brochure Now at http://www.reportsnreports.com/contacts/requestsample.aspx?name=232484 .

The Injectable drug delivery market by facility of use is segmented into hospitals and clinics, home care settings, and other facilities of use. The hospitals and clinics segment is expected to account for largest share of market, primarily due to rising incidence of chronic diseases such as diabetes and cancer which require a large number of injectables for their treatment.

Report defines, describes, & forecasts injectable drug delivery market on basis of type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, and facility of use. It provides detailed information regarding major factors influencing growth of market (drivers, restraints, opportunities, challenges).

#Table of Content
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Regulatory Scenario
7 Injectable Drug Delivery Market, By Type
8 Injectable Drug Delivery Market, By Formulation Packaging
9 Injectable Drug Delivery Market, By Therapeutic Application
10 Injectable Drug Delivery Market, By Usage Pattern
11 Injectable Drug Delivery Market, By Site of Administration
12 Injectable Drug Delivery Market, By Distribution Channel
13 Injectable Drug Delivery Market, By Facility of Use
14 Injectable Drug Delivery Market, By Region
15 Competitive Landscape
16 Company Profiles

Global injectable drug delivery market, in terms of value, projected to reach USD 624.50 billion by 2021 from USD 362.38 billion in 2016, at a CAGR of 11.5% during forecast period. Increase in use of biologics, increase in prevalence of chronic diseases, increasing occurrence of needle stick injuries, & benefits of injections (convenience, ease of use, & reduced pain) have driven growth of injectable drug delivery market.

Inquire for Discount Now on Injectible Drug Delievery Market Research Report Now at
https://www.reportsnreports.com/contacts/discount.aspx?name=232484 .

Injectable drug delivery market dominated by North America, followed by Europe, Asia, & Rest of the World. While North America expected to dominate market in 2018, Asia expected to grow at highest CAGR during forecast period. This growth in this market is attributed to rising incidence of chronic diseases & growing aging population.

Cancer segment is expected to register the highest CAGR during the forecast period. This is attributed to the launch of new vaccines and target therapies, such as antiangiogenics and antineoplastic monoclonal antibodies (mAbs). Asia is expected to be the fastest growing region in the market from 2016 to 2021 due to the rising incidence of chronic and autoimmune diseases, the rising aging population, and the high penetration of self-injection techniques &technologies in countries such as China, Japan, and India.

Prominent players in the injectable drug delivery market include Becton, Dickinson and Company (U.S.), Baxter International (U.S.), Pfizer (U.S.), Gerresheimer AG (Germany), Schott AG (Germany), Eli Lilly and Company (U.S.), and Terumo Corporation (Japan).

Click Here For More Information on Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel (Hospital), Patient Care Setting (Hospital, Home Care) - Forecast to 2021 Now at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=232484 .

Report provides clients market size information on various segments of injectable drug delivery market. This report also provides access to the quantitative data on market. This growth attributed to rising incidence of chronic & autoimmune diseases and rising aging population.

The report provides clients market size information on various segments of the injectable drug delivery market.
• Current and forecast assessment of the injectable drug delivery market
• Country-wise assessment of each of the segments
• Global market share analysis for major segments of the injectable drug delivery market
• Adoption Trends of injectable drug delivery for major geographic markets
• Five-year coverage of strategic developments of top players in the injectable drug delivery market
• Product Portfolio mapping of leading players in the injectable drug delivery market

ReportsnReports is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact Number: + 1 888 391 5441
Email Id - sales@reportsandreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Injectable Drug Delivery Market Set to Grow at 11.5% CAGR and Projected to Reach US$ 624.50 Billion to 2023 - Dominated by Becton, Dickinson and Company (U.S.), Baxter International (U.S.), Pfizer (U.S.), Gerresheimer AG (Germany) an Schott AG (Germany) here

News-ID: 1621524 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Injectable

Injectable Sumatriptan Market 2021 | Detailed Report
ReportsnReports publishes the report titled Injectable Sumatriptan that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital factors like cost,
Small-Molecule Injectable Market
The global Small-Molecule Injectable Market was valued at US$ 55.8 Bn in 2020. Expanding at a 7.3% CAGR, the market valuation is expected to top US$ 112.9 Bn by 2031, finds ESOMAR-certified consulting firm Future Market Insights (FMI) in a recent market analysis. The COVID-19 pandemic outbreak has sparked efforts to repurpose already-approved medicines for treatment. Several clinical studies are now being conducted on different antiviral medicines and small-molecule injectables that
Global Injectable Drug Delivery Devices Market | Global Injectable Drug Delivery …
The injectable drug delivery devices market involves of sales of conventional syringes, needle-free injectors, auto injectors and pen injectors. The market contains the sales of the Injectable devices that have been comprehensively utilized for several routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular and several others to cure the medical conditions vacillating from cancer to autoimmune disorders. The injectable drug delivery devices utilized in hospitals, clinics
Global Injectable Drug Delivery Market to 2028 |Retail Pharmacies, Injectable Dr …
Market Research Hub (MRH) has carefully analyzed this research study titled Injectable Drug Delivery Market: Self-injectors to Remain Fastest Growing Product Type During the Forecast Period: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028, which is available on its online portal. The aim of this assessment is to highlight the various projections expected to occur in the global market for Injectable Drug Delivery. Readers can gain knowledge related to prime
Ioversol Market Report 2018: Segmentation by Type (Ioversol 34% Injectable Solut …
Global Ioversol market research report provides company profile for China Resources Pharmaceutical (Shanghai) Co, HB Ocean, Novalek Pharmaceuticals Pvt. Ltd, Stellence Pharmscience Pvt. Ltd, A.S. Joshi & Company, Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co, Mallinckrodt Pharmaceuticals, Ultraject and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of
Injectable Targeted Therapy Market: Primary application of injectable targeted t …
Targeted delivery is a clinical treatment used to deliver medication in patients to increase the concentration of medication in some parts of the body. Target specific drug delivery is localized, prolonged, targeted and have protected drug interaction with the diseased tissue. The advantage of injectable targeted therapy was the decrease in frequency of the dosages that are delivered to the patient, it more uniform effect of the drug, reduction of